139 related articles for article (PubMed ID: 27072976)
1. Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis.
Jiang B; Chen JH; Yuan WZ; Ji JT; Liu ZY; Wu L; Tang Q; Shu XG
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):278-284. PubMed ID: 27072976
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
Zu G; Ji A; Zhou T; Che N
Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
[TBL] [Abstract][Full Text] [Related]
4. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of SIRT1-Autophagy Axis in Gastric Cancer.
Qiu G; Li X; Wei C; Che X; He S; Lu J; Wang S; Pang K; Fan L
Dis Markers; 2016; 2016():6869415. PubMed ID: 28070138
[No Abstract] [Full Text] [Related]
6. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
9. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis.
Wang C; Yang W; Dong F; Guo Y; Tan J; Ruan S; Huang T
Oncotarget; 2017 Sep; 8(39):66343-66351. PubMed ID: 29029516
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
12. Co-ordinated overexpression of SIRT1 and STAT3 is associated with poor survival outcome in gastric cancer patients.
Zhang S; Huang S; Deng C; Cao Y; Yang J; Chen G; Zhang B; Duan C; Shi J; Kong B; Friess H; Zhao N; Huang C; Huang X; Wang L; Zou X
Oncotarget; 2017 Mar; 8(12):18848-18860. PubMed ID: 28061480
[TBL] [Abstract][Full Text] [Related]
13. Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance.
Feng AN; Zhang LH; Fan XS; Huang Q; Ye Q; Wu HY; Yang J
Int J Surg Pathol; 2011 Dec; 19(6):743-50. PubMed ID: 21865267
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers.
Yu FY; Xu Q; Wu DD; Lau AT; Xu YM
PLoS One; 2016; 11(8):e0159801. PubMed ID: 27483432
[TBL] [Abstract][Full Text] [Related]
15. Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis.
Sun M; Du M; Zhang W; Xiong S; Gong X; Lei P; Zha J; Zhu H; Li H; Huang D; Gu X
Front Endocrinol (Lausanne); 2019; 10():121. PubMed ID: 30930849
[No Abstract] [Full Text] [Related]
16. The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.
Wang Z; Liu H; Shen Z; Wang X; Zhang H; Qin J; Xu J; Sun Y; Qin X
BMC Cancer; 2015 Oct; 15():766. PubMed ID: 26497045
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of SIRT1 gene in gastric adenocarcinoma.
Özcan Ö; Belli AK; Sakallı Çetin E; Kara M; Çelik Öİ; Kaplan M; Kayılıoğlu SI; Dönmez C; Polat M
Turk J Gastroenterol; 2019 Apr; 30(4):326-330. PubMed ID: 30945643
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
19. Serum
Otsuka R; Morishita H; Iida K; Hayano K; Murakami K; Endo S; Toyozumi T; Matsumoto Y; Kurata Y; Kinoshita K; Sasaki T; Iida S; Nishioka Y; Matsubara H
Anticancer Res; 2023 Apr; 43(4):1485-1491. PubMed ID: 36974791
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis.
Du P; Liu Y; Ren H; Zhao J; Zhang X; Patel R; Hu C; Gan J; Huang G
Gastric Cancer; 2017 Mar; 20(2):235-245. PubMed ID: 26984468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
